Breaking News

Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here

Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Close

Gilead Sciences Inc (GILDCL)

	Symbol	Exchange	Currency
	GILD	NASDAQ	USD	Real-time
	GILD	Mexico	MXN	Delayed
	GGILD	Milan	EUR	Real-time
	GILD	Xetra	EUR	Delayed
	GILD	Frankfurt	EUR	Delayed
	GILD	TradeGate	EUR	Delayed
	GILD	Santiago	USD	Delayed
	GILDCL	Santiago	CLP	Delayed
	GILD	Buenos Aires	ARS	Delayed
	GILD	Vienna	EUR	Delayed

Add to/Remove from a Portfolio Add to Watchlist

0.00 0.00 0.00%

30/11 - Closed. Currency in CLP ( Disclaimer )

Volume: 0
Bid/Ask: 0.00 / 0.00
Day's Range: 0.00 - 0.00

Type: Equity

Market: Chile

ISIN: US3755581036

News
Analysis & Comment

GILDCL News

This page features the latest Gilead share news. Assess the latest information about the Gilead stock.

Amazon, Pinterest Fall Premarket; Chevron, P&G Rise

Amazon, Pinterest Fall Premarket; Chevron, P&G Rise By Investing.com - Jul 30, 2021

By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, July 30th. Please refresh for updates. Amazon (NASDAQ:AMZN) stock fell 6.9% after the e-commerce giant’s extraordinary...

Gilead Earnings, Revenue beat in Q2

Gilead Earnings, Revenue beat in Q2 By Investing.com - Jul 29, 2021

Investing.com - Gilead (NASDAQ:GILD) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Gilead announced earnings per share of $1.87 on...

EU signs deal with GSK for supply of potential COVID drug

EU signs deal with GSK for supply of potential COVID drug By Reuters - Jul 28, 2021 1

BRUSSELS (Reuters) -The European Union has signed a contract with GlaxoSmithKline for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against...

Zoom, Facebook and Delta Air Lines Fall Premarket

Zoom, Facebook and Delta Air Lines Fall Premarket By Investing.com - Jul 19, 2021

By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, July 19th. Please refresh for updates. Zoom Video Communications (NASDAQ:ZM) stock fell 2.2% after the video...

U.S. approves Roche drug for emergency use against severe COVID-19

U.S. approves Roche drug for emergency use against severe COVID-19 By Reuters - Jun 25, 2021

(Reuters) -U.S. health regulators have approved Roche's arthritis drug Actemra for emergency use to treat hospitalized COVID-19 patients, giving an extra boost to a medicine that was already allowed...

EU regulator backs extending approval for remdesivir for another year

EU regulator backs extending approval for remdesivir for another year By Reuters - May 21, 2021

(Refiles to add dropped word "billion" in paragraph 5) (Reuters) - The European Medicines Agency (EMA) on Friday recommended extending conditional marketing approval by a year for Gilead Sciences...

New antibody drug helps patients breathe; virus may insert genetic fragments into genetic code

New antibody drug helps patients breathe; virus may insert genetic fragments into genetic code By Reuters - May 10, 2021

By Nancy Lapid (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by...

Twitter, Apple and Chevron Fall Premarket; Amazon Rises

Twitter, Apple and Chevron Fall Premarket; Amazon Rises By Investing.com - Apr 30, 2021

By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, April 30th. Please refresh for updates. Twitter (NYSE:TWTR) stock slumped over 12% after the social media giant offered...

Gilead Earnings beat, Revenue misses In Q1

Gilead Earnings beat, Revenue misses In Q1 By Investing.com - Apr 29, 2021

Investing.com - Gilead (NASDAQ:GILD) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Gilead announced earnings per share of...

Economic Calendar - Top 5 Things to Watch This Week

Economic Calendar - Top 5 Things to Watch This Week By Investing.com - Apr 25, 2021

By Jesse Cohen Investing.com - Market participants are bracing for heightened volatility as the coming week will be dominated by several market-moving events, including a deluge of earnings news,...

1 2 3 4 5 6 7 8 9 10

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Oc Masai Apr 27, 2021 7:54

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good job GILD. bullish move forward

0 0

Ashraf Elgendy Mar 07, 2021 13:03

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...

2 1

RM RM Mar 01, 2021 21:53

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Up Again

1 0

Ken Laing Oct 23, 2020 18:43

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Time to load up before the big rise coming next week

3 3

Iggy Maldon Jul 30, 2020 20:22

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Classic pump n’ dump. What a shambles

5 1

RM RM May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Will reach above 95

10 5

Chili Daug May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

when? hahah

0 0

SAGAR AGARWAL May 15, 2020 14:52

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good time to accumulate.

4 1

Khizer Malik May 14, 2020 11:04

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr

8 2

Willy Chin Apr 23, 2020 18:14

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

High chance to be trading above 90, good long stock

9 4

Viktor Veselý Apr 12, 2020 7:48

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.

4 3

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="204313794">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="204313794" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="204313794">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="204313794">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200889478">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200889478" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200889478">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200889478">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	FTSE 100	7,541.85	+26.10	+0.35%
	DAX	13,697.41	+70.70	+0.52%
	Euro Stoxx 50	3,777.38	+21.32	+0.57%
	US 30	33,992.0	-7.0	-0.02%
	US 500	4,282.6	-1.1	-0.03%
	Nikkei 225	28,942.14	-280.63	-0.96%
	GBP Index	73.66	-0.19	-0.25%

	Brent Oil	96.56	+2.91	+3.11%
	Crude Oil WTI	90.62	+0.12	+0.13%
	Gold	1,771.55	+0.35	+0.02%
	Silver	19.427	-0.037	-0.19%
	Copper	3.6402	-0.0070	-0.19%
	London Cocoa	1,757.00	-4.00	-0.23%
	London Wheat	252.50	-7.50	-2.88%

	GBP/USD	1.1934	+0.0004	+0.03%
	EUR/USD	1.0088	0.0000	0.00%
	USD/JPY	135.87	-0.01	-0.01%
	EUR/GBP	0.8454	+0.0001	+0.01%
	USD/CAD	1.2947	0.0000	0.00%
	GBP/JPY	162.14	+0.04	+0.02%
	AUD/USD	0.6916	-0.0002	-0.03%

	Lloyds Banking	45.72	-0.07	-0.15%
	Vodafone Group PLC	121.56	-0.22	-0.18%
	Barclays	168.50	-0.18	-0.11%
	BT Group	157.25	+0.15	+0.10%
	HSBC	540.70	-4.40	-0.81%
	BHP Group Ltd	2,371.50	+25.50	+1.09%
	Exxon Mobil	94.38	+2.18	+2.36%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILDCL	0.00	0.00	0.00%

	Name	Last	Chg. %	Vol.
	Glencore	498.25	+2.37%	37.25M
	BP	442.00	+2.58%	36.26M
	HSBC	540.70	-0.81%	33.49M
	Shell	2,217.5	+1.63%	9.91M
	GSK plc	1,402.00	-0.95%	9.22M
	Rio Tinto PLC	4,946.5	+1.19%	2.52M
	London Stock Exchange	8,532.0	+1.16%	1.90M

	Name	Last	Chg. %	Vol.
	Octopus Renewables	11,473.00	+1000.00%	303.93K
	Dampskibsselskabet Norden AS	431.10	+21.06%	21.62K
	Power Metal Resources	1.4250	+18.75%	14.20M
	Cineworld	9.75	+18.32%	124.44M
	Empire Metals Ltd	1.200	+17.07%	8.38M
	OKYO Pharma	2.750	+17.02%	723.43K
	Invinity Energy Systems PLC	52.500	+15.38%	1.00M

	Name	Last	Chg. %	Vol.
	Dassault Aviation	148.00	-83.97%	11.45K
	H Lundbeck B	29.91	-82.78%	309.69K
	BioGaia B	94.52	-81.66%	0.29K
	Dassault Systemes	42.98	-79.47%	259.22K
	Tilray	3.98	-78.02%	0
	Atlas Copco B	106.00	-71.95%	23.99K
	Tomra Systems	238.85	-31.32%	9.57K